anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

216,421-216,480 of 319,975

filter-aware
01
Slide 1
The slide uses Python-like code snippets as a design element to illustrate the technical nature of the drug creation process.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Attention1 hit
02
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Attention1 hit
03
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Attention1 hit
04
Includes decorative code snippets in the background and a stylized geometric logo.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Attention1 hit
05
Includes code snippets as decorative elements in the background.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
06
Uses a timeline chart to show the acceleration of AI technology (Image recognition -> NLP -> DALL-E -> ChatGPT) to set the stage for the company's value proposition.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
07
The diagram shows a circular, inefficient optimization process (affinity, developability, toxicity) leading to suboptimal candidates.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
The slide uses a comparison frame to contrast small molecule data availability with biologic data scarcity.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
09
The slide uses a process flow to explain the technical solution.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
10
The slide uses a circular flywheel diagram to represent the iterative process.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
11
The slide uses QR codes to link to specific research papers (Shanehsazzadeh et al. 2023, Constant et al. 2023, Bachas et al. 2022).Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Call to AdventureLoop · Golden Circle1 hit
01
Slide 1
The slide uses code snippets as a visual metaphor for the company's computational drug discovery process.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
02
Absci | Investor Presentation Deck | 48 slidesAbsci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
03
Uses a rhetorical question to frame the company's value proposition as a paradigm shift.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
Uses a process diagram to illustrate the iterative, inefficient nature of traditional drug discovery.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Uses a visual comparison between small molecule and biologic data availability to frame the problem.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Situation & Context1 hit
06
The slide uses a process flow to explain the technical solution.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Situation & Context1 hit
07
The slide uses a metaphor to frame the company's value proposition against the backdrop of low clinical trial success rates.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
08
The slide uses a flywheel-style diagram to represent the iterative nature of the platform.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
09
The slide uses a circular process diagram to illustrate the feedback loop between data, AI, and wet lab validation.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
10
The slide uses a linear process flow to demonstrate the end-to-end nature of the platform.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
11
The 'o' in 'zero-shot' is replaced by a molecular/network graphic.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
12
The slide uses a process flow diagram to explain the company's core technology platform.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
13
The slide uses a 5-step process flow diagram to explain the technical methodology.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
14
The slide highlights the efficacy of the company's de novo design model by comparing it against a known benchmark (trastuzumab).Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
15
Case study slide demonstrating model specificity and performance improvement over existing biological datasets.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
16
The heatmap shows edit distances between pairs of HCDR3 sequences, and the table lists specific examples with their respective edit distances and binding affinities (-Log10(KD)).Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
17
The slide highlights 'Zero-shot' capability, meaning the model generates binders without having seen the target or homologs, and without lead optimization.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
18
The slide showcases five distinct protein-antibody complex structures to demonstrate the versatility of the de novo design platform.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
19
The slide uses a pull-quote from a scientific paper to establish authority.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
20
The slide uses a process flow framework to show the integration of AI at specific stages of therapeutic development.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
21
Uses a Venn diagram to represent the intersection of three properties optimized by AI.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
22
The slide uses a visual comparison between a small sampled space (50k) and a much larger hypothetical sequence space (7 million) to demonstrate the efficiency of the AI approach.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
23
Case study slide showing correlation metrics (Pearson, Spearman, RMSE) and a histogram comparing predicted affinity to Trastuzumab.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
24
The slide uses a process flow diagram to show AI input leading to improved antibody outcomes.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
25
The slide uses three charts: two line charts showing optimization over generations and one scatter plot showing the distribution of variants.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
26
The slide uses a histogram to visualize the distribution of binding affinity (-log10(KD)) for designed variants compared to the wild-type Trastuzumab baseline.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
27
Uses a three-column layout to demonstrate versatility of the platform across different biological applications.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
28
The slide uses a linear process flow to explain the company's core technology platform.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
29
The letter 'o' in 'potential' is replaced by the company's circular logo graphic.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
30
Includes a biological diagram of TLS and a Kaplan-Meier survival curve.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
31
The workflow follows a two-row process flow, starting with patient samples and ending with target antigen confirmation.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
32
The slide highlights key performance indicators of their antibody discovery platform and the disease areas they are targeting.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
33
The slide uses a two-column layout to contrast the partners (left) with the value derived from those partnerships (right).Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
34
The slide uses a linear process flow to demonstrate the integration of AI across the drug development lifecycle.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
35
The slide explains the mechanism of incorporating nsAA into mAbs to create ADC precursors.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
36
The slide uses a split-column layout to contrast the platform's core capability with its downstream applications.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
37
The slide uses a series of icons representing E. coli cells to illustrate three key technical advantages of the proprietary cell line.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
38
The slide uses a bar chart to show relative expression across different nsAA incorporation counts, alongside a structural model of the antibody.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
39
The slide uses a mass spectrometry plot to visualize the shift from the base molecule to the conjugated product.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
40
Uses a four-column layout to categorize value propositions.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
41
PoS stands for Probability of Success. The slide uses a timeline framework to contrast traditional drug development with Absci's approach.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
42
The chart uses a dot-plot visualization to represent revenue accumulation over time, categorized by development stages.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
43
The slide uses a mix of imagery and key metrics to establish credibility.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
44
Uses authority-citation to build credibility.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
45
Includes a dog as 'Chief Morale Officer' as a lighthearted team member addition.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
46
The slide uses a grid layout to display headshots and names for the Board of Directors, and a mix of headshots and corporate/academic logos for the Scientific Advisory Board.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
47
The slide uses a growth curve to visualize the progression of technological capabilities over time.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
48
Absci | Investor Presentation Deck | 48 slidesAbsci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
33
VinFast | Investor Presentation Deck | 33 slidesVinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations 1 hit